These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 27638348)

  • 21. Impact of brief exposure to antifungal agents on the post-antifungal effect and hemolysin activity of oral Candida albicans.
    Ellepola AN; Khajah R; Jayatilake S; Samaranayake L; Sharma P; Khan Z
    J Appl Oral Sci; 2015; 23(4):412-8. PubMed ID: 26398514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psidium guajava L. and Psidium brownianum Mart ex DC.: Chemical composition and anti - Candida effect in association with fluconazole.
    Morais-Braga MFB; Sales DL; Carneiro JNP; Machado AJT; Dos Santos ATL; de Freitas MA; Martins GMAB; Leite NF; de Matos YMLS; Tintino SR; Souza DSL; Menezes IRA; Ribeiro-Filho J; Costa JGM; Coutinho HDM
    Microb Pathog; 2016 Jun; 95():200-207. PubMed ID: 27085299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carboxylic acid and phosphate ester derivatives of fluconazole: synthesis and antifungal activities.
    Nam NH; Sardari S; Selecky M; Parang K
    Bioorg Med Chem; 2004 Dec; 12(23):6255-69. PubMed ID: 15519168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potent
    Li DD; Chai D; Huang XW; Guan SX; Du J; Zhang HY; Sun Y; Jiang YY
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel Nystatin A₁ derivatives exhibiting low host cell toxicity and antifungal activity in an in vitro model of oral candidosis.
    Boros-Majewska J; Salewska N; Borowski E; Milewski S; Malic S; Wei XQ; Hayes AJ; Wilson MJ; Williams DW
    Med Microbiol Immunol; 2014 Oct; 203(5):341-55. PubMed ID: 24924305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclosporine A decreases the fluconazole minimum inhibitory concentration of Candida albicans clinical isolates but not biofilm formation and cell growth.
    Wibawa T; Nurrokhman ; Baly I; Daeli PR; Kartasasmita G; Wijayanti N
    Trop Biomed; 2015 Mar; 32(1):176-82. PubMed ID: 25801268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic antifungal effect of lactoferrin with azole antifungals against Candida albicans and a proposal for a new treatment method for invasive candidiasis.
    Kobayashi T; Kakeya H; Miyazaki T; Izumikawa K; Yanagihara K; Ohno H; Yamamoto Y; Tashiro T; Kohno S
    Jpn J Infect Dis; 2011; 64(4):292-6. PubMed ID: 21788703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The synergy of honokiol and fluconazole against clinical isolates of azole-resistant Candida albicans.
    Jin J; Guo N; Zhang J; Ding Y; Tang X; Liang J; Li L; Deng X; Yu L
    Lett Appl Microbiol; 2010 Sep; 51(3):351-7. PubMed ID: 20681969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo analysis of monotherapy and dual therapy with ethyl caffeate and fluconazole on virulence factors of Candida albicans and systemic candidiasis.
    Wang T; Pan M; Xiao N; Wu J; Wang Q; Cheng T; Yan G; Wu D; Li N; Shao J
    J Glob Antimicrob Resist; 2021 Dec; 27():253-266. PubMed ID: 34700054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antifungal activity and cytotoxicity of extracts and triterpenoid saponins obtained from the aerial parts of Anagallis arvensis L.
    Soberón JR; Sgariglia MA; Pastoriza AC; Soruco EM; Jäger SN; Labadie GR; Sampietro DA; Vattuone MA
    J Ethnopharmacol; 2017 May; 203():233-240. PubMed ID: 28389355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible mechanisms of the antifungal activity of fluconazole in combination with terbinafine against Candida albicans.
    Khodavandi A; Alizadeh F; Vanda NA; Karimi G; Chong PP
    Pharm Biol; 2014 Dec; 52(12):1505-9. PubMed ID: 24863276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The combination of minocycline and fluconazole causes synergistic growth inhibition against Candida albicans: an in vitro interaction of antifungal and antibacterial agents.
    Shi W; Chen Z; Chen X; Cao L; Liu P; Sun S
    FEMS Yeast Res; 2010 Nov; 10(7):885-93. PubMed ID: 20707818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reassessment of the in vitro synergistic effect of fluconazole with the non-steroidal anti-inflammatory agent ibuprofen against Candida albicans.
    Arai R; Sugita T; Nishikawa A
    Mycoses; 2005 Jan; 48(1):38-41. PubMed ID: 15679664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of anti-Candida potential of geranium oil constituents against clinical isolates of Candida albicans differentially sensitive to fluconazole: inhibition of growth, dimorphism and sensitization.
    Zore GB; Thakre AD; Rathod V; Karuppayil SM
    Mycoses; 2011 Jul; 54(4):e99-109. PubMed ID: 20337938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The comparative study of antifungal activity of Syzygium aromaticum, Punica granatum and nystatin on Candida albicans; an in vitro study.
    Mansourian A; Boojarpour N; Ashnagar S; Momen Beitollahi J; Shamshiri AR
    J Mycol Med; 2014 Dec; 24(4):e163-8. PubMed ID: 25442923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic and drug-resistant reversing effects of diorcinol D combined with fluconazole against Candida albicans.
    Li Y; Chang W; Zhang M; Li X; Jiao Y; Lou H
    FEMS Yeast Res; 2015 Mar; 15(2):. PubMed ID: 25752309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Betamethasone augments the antifungal effect of menadione--towards a novel anti-Candida albicans combination therapy.
    Jakab Á; Emri T; Sipos L; Kiss Á; Kovács R; Dombrádi V; Kemény-Beke Á; Balla J; Majoros L; Pócsi I
    J Basic Microbiol; 2015 Aug; 55(8):973-81. PubMed ID: 25707543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of chemosensitizers on minimum inhibitory concentrations of fluconazole in Candida albicans.
    Bulatova NR; Darwish RM
    Med Princ Pract; 2008; 17(2):117-21. PubMed ID: 18287794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural optimization of berberine as a synergist to restore antifungal activity of fluconazole against drug-resistant Candida albicans.
    Liu H; Wang L; Li Y; Liu J; An M; Zhu S; Cao Y; Jiang Z; Zhao M; Cai Z; Dai L; Ni T; Liu W; Chen S; Wei C; Zang C; Tian S; Yang J; Wu C; Zhang D; Liu H; Jiang Y
    ChemMedChem; 2014 Jan; 9(1):207-16. PubMed ID: 24376206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antifungal activity of a trypsin inhibitor from Salvia hispanica L. (chia) seeds against fluconazole-resistant strains of Candida spp. and evaluation of its toxicity in vitro.
    Nogueira FC; de Souza AÁ; Araújo NMS; de Souza LAL; Guimarães Gomes Silva R; de Oliveira Bezerra de Sousa D; Coêlho Cavalcanti B; de Moraes Filho MO; Gurgel do Amaral Valente Sá L; Vitoriano Nobre Júnior H; de Oliveira HD
    Braz J Microbiol; 2024 Jun; 55(2):1205-1217. PubMed ID: 38594492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.